Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Gene Medicine|November 15, 2005
Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virusLuca Perabo, Jan Endell, Susan King, et al.
Lab on a Chip|April 24, 2012
Macroporous silicon chips for laterally resolved, multi-parametric analysis of epithelial barrier functionStefanie Michaelis, Christina E Rommel, Jan Endell, et al.
Cancer Research|March 11, 2010
Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinomaSilke Wolterink, Gerhard Moldenhauer, Mina Fogel, et al.
Journal of Virology|September 6, 2005
Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear traffickingKerstin Lux, Nico Goerlitz, Stefanie Schlemminger, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2022
Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapyJung Hyun Her, Dominik Pretscher, Maria Patra-Kneuer, et al.
Oncotarget|January 11, 2015
α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myelomaKatharina Teiluf, Christof Seidl, Birgit Blechert, et al.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
Nature Communications|August 21, 2025
The bispecific innate cell engager AFM28 eliminates CD123<sup>+</sup> leukemic stem and progenitor cells in AML and MDSNanni Schmitt, Jana-Julia Siegler, Alexandra Beck, et al.
Blood|October 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRSR Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, et al.
Pageof 1